Orthofix Medical (OFIX) Cash & Current Investments (2009 - 2026)

Orthofix Medical has disclosed Cash & Current Investments across 18 years of filings, most recently posting $120.9 million for Q1 2026.

• Quarterly Cash & Current Investments rose 99.94% year-over-year to $120.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $120.9 million (up 99.94% YoY) and the FY2025 annual result came in at $85.1 million, down 0.73% from the prior year.
• Cash & Current Investments rose to $120.9 million in Q1 2026, from $85.1 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $120.9 million in Q1 2026 and troughed at $28.9 million in Q2 2024.
• A 5-year average of $57.1 million and a median of $51.7 million in 2022 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2022 — Cash & Current Investments plunged 42.29% — and 2025, when it soared 137.96%.
• Tracing OFIX's Cash & Current Investments over 5 years: stood at $50.7 million in 2022, then slipped by 25.53% to $37.8 million in 2023, then soared by 127.08% to $85.7 million in 2024, then retreated by 0.73% to $85.1 million in 2025, then soared by 42.01% to $120.9 million in 2026.
• Business Quant data shows OFIX's Cash & Current Investments at $120.9 million in Q1 2026, $85.1 million in Q4 2025, and $65.9 million in Q3 2025.